Correction to: Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1.

The original article [1] contains a number of small errors which the authors would like to clarify.

Correction

The original article [1] contains a number of small errors which the authors would like to clarify:

In Fig. 1a of the original article, FGF10 concentration should be 50 ng/ml – as correctly stated in the Methods section – instead of 100 μg/ml.

Also in Fig. 1a of the original article, Activin A and EGF concentrations should both be 100 ng/ml – as correctly stated in the Methods section – instead of 100 μg/ml.

In the Methods section under the sub-heading “Differentiation of human pluripotent stem cells into pancreatic progenitor”, the term, ‘50 ng/ml hFGF10’ should be omitted from the following sentence:

“At the end of stage 3, media were changed to DMEM supplemented with 1% vol/vol B27, 0.25 mM vitamin C, 50 ng/ml hFGF10, 50 ng/ml hNOGGIN, 100 ng/ml hEGF, and 10 mM nicotinamide (Sigma, USA) for 4 days of stage 4 treatment for each protocol (Fig. 1a).”

FGF10 was only added during stages 2 & 3 of differentiation as correctly depicted in Fig. 1a.

The corrected version of Fig. 1a can be viewed ahead.